---
$id: https://graph.org.ai/products/commodity/51271801
$type: Product
source: UNSPSC
code: "51271801"
title: "Aptocaine"
class: "51271800"
classTitle: "Anaesthetic amines"
family: "51270000"
familyTitle: "Anaesthetic drugs and related adjuncts and analeptics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Aptocaine

**UNSPSC Code**: 51271801
**Class**: [Anaesthetic amines](Anaesthetic amines.mdx)
**Family**: [Anaesthetic drugs and related adjuncts and analeptics](../Anaesthetic drugs and related adjuncts and analeptics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anesthetic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 08K838NNTE. European Medicines Agency schedules Aptocaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05549MIG. Aptocaine generally arises in the molecular formula C14H20N2O. The term APTOCAINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 23, no. 10 1969, list 9.) APTOCAINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule aptocaine under HS 29339990 and SITC 51577. As of Q4 2014, APTOCAINE remains the US FDA Preferred Term for this commodity. Aptocaine bears US NLM identifiers UMLS ID C0052238 and NCI Concept Code C72172. SMILES: O=C(NC1C(CCCC1)C)C(N1CCCC1)C.

